Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Deceased Organ Donor Interventions to Protect Kidney Graft Function
NCT02525510 · View on ClinicalTrials.gov ↗
Study Summary
To protect kidney function during the transplantation process by comparing mild hypothermia in the deceased organ donor before organs are recovered and pulsatile perfusion of the kidney after recovery and prior to transplantation.
Conditions Studied
Interventions
- OTHER Pump Eligible - Normothermia - Pump Both Kidneys
- OTHER Pump Eligible - Hypothermia and Pump Right Kidney
- OTHER Pump Eligible - Hypothermia and Pump Left Kidney
- OTHER Not Pump Eligible - Normothermia
- OTHER Not Pump Eligible - Hypothermia
Study Locations (7)
Texas
- Southwest Transplant Alliance — Dallas
- LifeGift — Houston
Arizona
- Donor Network of Arizona — Phoenix
California
- U C San Francisco — San Francisco
Colorado
- Donor Alliance — Denver
Minnesota
- LifeSource — Minneapolis
Oregon
- Pacific Northwest Transplant Bank — Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,427 participants |
| Start Date | 2017-07-26 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02525510
The ClinicalTrials.gov registry entry for NCT02525510 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,427 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francis, which has 1,574 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 4 conditions, with Delayed Graft Function appearing as the primary indexed condition, and to 5 interventions — of which Pump Eligible - Normothermia - Pump Both Kidneys is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02525510 reports 7 study locations spanning 6 distinct geographic areas — top geographies include Texas, Arizona, California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02525510 about?
NCT02525510 is a clinical study titled "Deceased Organ Donor Interventions to Protect Kidney Graft Function". To protect kidney function during the transplantation process by comparing mild hypothermia in the deceased organ donor before organs are recovered and pulsatile perfusion of the kidney after recovery and prior to transplantation.
What is the current status of trial NCT02525510?
This trial is currently completed. It is a NA study. The enrollment target is 1,427 participants. The study started on 2017-07-26. Estimated completion is 2022-06-01.
What conditions does trial NCT02525510 study?
This clinical trial studies the following conditions: Delayed Graft Function, Brain Death, Organ Donation, Organ Transplant Failure or Rejection. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT02525510?
The interventions under investigation include: Pump Eligible - Normothermia - Pump Both Kidneys (OTHER), Pump Eligible - Hypothermia and Pump Right Kidney (OTHER), Pump Eligible - Hypothermia and Pump Left Kidney (OTHER), Not Pump Eligible - Normothermia (OTHER), Not Pump Eligible - Hypothermia (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT02525510?
This trial is sponsored by University of California, San Francis, which has 1,574 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02525510 being conducted?
This trial has 7 study locations across Arizona, California, Colorado, Minnesota, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.